Invirsa obtains license from Nationwide Children’s Hospital to fight respiratory diseases
Columbus, OH – Dec. 18, 2020 – Invirsa, a Columbus-based pharmaceutical company, today announced execution of a license agreement with the Abigail Wexner Research Institute (AWRI) at Nationwide Children’s Hospital as Invirsa seeks to broaden its treatment platform to address respiratory diseases. The announcement coincides with Invirsa’s securing a $16.9 million contract from the government…
Details